You are here

Clinical Trials: Kidney Disease



Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Friday, March 9, 2018 - 12:00
Condition:   Renal Cirrhosis
Intervention:   Biological: MSC
Sponsor:   Nanjing Medical University
Not yet recruiting
Posted: Monday, October 30, 2017 - 12:00
Conditions:   Chronic Kidney Diseases;   Diabetes Mellitus;   Diabetic Nephropathies
Interventions:   Dietary Supplement: Fisetin;   Drug: Placebo oral capsule
Sponsor:   Mayo Clinic
Posted: Thursday, October 26, 2017 - 12:00
Conditions:   Mesenchymal Stem Cells;   Chronic Kidney Diseases;   Renal Interstitial Fibrosis
Interventions:   Drug: Treatment group;   Drug: Control group
Sponsor:   The Affiliated Hospital of Xuzhou Medical University
Posted: Tuesday, August 8, 2017 - 12:00
Condition:   Diabetic Nephropathies
Intervention:   Biological: Wharton Jelly Mesenchymal stem cells
Sponsors:   Sophia Al-Adwan;   Jordan University of Science and Technology;   An-Najah National University
Not yet recruiting - verified September 2017
Posted: Friday, January 6, 2017 - 12:00
Condition:   Acute Kidney Injury
Interventions:   Biological: SBI-101;   Device: Sham
Sponsor:   Sentien Biotechnologies, Inc.
Not yet recruiting - verified January 2017
Posted: Thursday, October 13, 2016 - 12:00
Condition:   Moderate to Severe Chronic Kidney Disease
Intervention:   Drug: Elixcyte
Sponsors:   UnicoCell Biomed CO. LTD;   A2 Healthcare Taiwan Corporation
Not yet recruiting - verified October 2016
Posted: Thursday, October 6, 2016 - 12:00
Conditions:   Type 2 Diabetes Mellitus;   Chronic Kidney Disease
Interventions:   Drug: Canagliflozin;   Drug: Placebo
Sponsors:   George Washington University;   Janssen Scientific Affairs, LLC
Recruiting - verified September 2016
Posted: Thursday, September 8, 2016 - 12:00
Condition:   Hemolytic Uremic Syndrome
Intervention:   Biological: Extra blood draw samples
Sponsor:   Assistance Publique Hopitaux De Marseille
Recruiting - verified September 2016
Posted: Thursday, June 2, 2016 - 12:00
Conditions:   End Stage Renal Disease (ESRD);   Vascular Access Complication
Intervention:   Biological: Adipose Derived Mesenchymal Stem Cells (AMSC)
Sponsor:   Mayo Clinic
Not yet recruiting - verified June 2016
Posted: Tuesday, March 22, 2016 - 12:00
Condition:   Chronic Kidney Disease
Interventions:   Drug: Group 2: Dasatinib;   Drug: Group 2: Quercetin
Sponsor:   Mayo Clinic
Recruiting - verified July 2016